AstraZeneca Says Its Coronavirus Vaccine Triggers Immune Response Among Adults-CNBC

British pharmaceutical giant AstraZeneca on Monday said its potential Covid-19 vaccine has produced a similar immune response in older and younger adults. AstraZeneca, which is developing its potential Covid-19 vaccine in collaboration with the University of Oxford, said adverse responses to the vaccine among the elderly were also found to be lower. CNBC, 10/26/2020

•   Print
•   Email
•   Share
•   Tweet